yeah with the exception of "details of both study designs to be...

yeah with the exception of "details of both study designs to be released in Q2 calendar 2018", the announcement does not shed any light as to timeframes for a start date of either FSGS or DN trials...I read it as a delay, especially for the FSGS trial since patient recruitment was meant to be underway as of this quarter.

on a positive though, looks as though the DN study may be taking place sooner than expected, and if they start and run both trials at the same time, whatever those trials may look like I don't know, then at least we will have some speculative money coming in for the 2 X trial ride.

I don't know how many 2b clinical trials in CKD are running or planned at the moment...having 2 of them run at the same time will surely attract new interest to the stock...you would think so anyway.